Skip to content
Sunday, April 2, 2023
HealthCare Middle East & Africa Logo 500

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
  • THE MAGAZINE
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Amanat Holdings unveils its single platform Amanat Healthcare
  • Fujifilm expands its endoscopy portfolio with the launch of CAD EYE Upper GI in India
  • Redcliffe Labs snaps up Indian diagnostics chain Medicentre Sonography & Clinical Lab
  • JICA signs US$330M loan agreement for Egypt's road to universal health insurance
  • New manufacturing unit to open at the VASCERA complex in Egypt
  • WHO steps up healthcare response for Somali refugees in Ethiopia's Dollo Zone
  • Zanzibar's health sector gets a boost as EAC launches health scorecard for maternal and child health
  • Kenya to commence local production of drugs and vaccines in collaboration with Belgium company
  • Dr. Moopen’s family invests US$56M in Aster DM Healthcare, raises stake to 41.88%
  • Takeda ramps up production capacity for plasma-derived therapies with US$765M investment in Japanese facility
You are here
  • Home
  • Israel

Tag: Israel

Teva Pharmaceuticals appoints Richard Francis CEO

27 November 202227 November 2022

ISRAEL —Teva Pharmaceuticals Industries Ltd. has appointed Richard Francis as President and Chief Executive Officer, effective January 1, 2023. Current CEO, Kåre Schultz, will retire effective December 31, 2022. Kare…

Read More

Pfizer & CytoReason extend multi-year partnership for AI-driven drug discovery

26 September 202226 September 2022

ISRAEL -CytoReason has extended its multi-year partnership with Pfizer to use CytoReason’s artificial intelligence technology for Pfizer’s drug development programs. According to the deal, Pfizer will invest US$20m in equity,…

Read More

Global consortium seeks to develop breakthrough RNA-based anti-cancer immunotherapy

25 September 202225 September 2022

ISRAEL – The Hadassah Cancer Research Institute (HCRI) at the Hadassah University Medical Center in Jerusalem, Israel, is to lead CanceRNA, a global consortium aiming to apply RNA-based therapeutics to…

Read More

Ibex Medical Analytics launches new cancer diagnostics platform

6 September 20226 September 2022

ISRAEL – Israel-based Ibex Medical Analytics has rolled out its new-generation solution, Galen 3.0, for the detection and diagnosis of multiple tissue types across various digital pathology workflows. Galen uses…

Read More

UltraSight acquires CE Certification for new cardiac AI Technology

29 August 202229 August 2022

SPAIN- Israeli cardiac imaging company UltraSight, has announced that its AI guiding software for cardiac ultrasound now carries the CE Mark. The digital health pioneer received the CE Mark after…

Read More

New Survey indicates that 62% of recipients of the monkeypox vaccine report no side effects

23 August 202223 August 2022

ISRAEL- According to a recent study on the adverse effects of the monkeypox vaccine, the majority of vaccine recipients in Israel reported no apparent symptoms. Since the outbreak started, this…

Read More

Teva closes on US$4.25bn deal to settle US-wide opioid lawsuit

29 July 202229 July 2022

ISRAEL –Teva Pharmaceutical has reached an agreement in principle to settle thousands of lawsuits accusing it of abetting the opioid crisis in the US for up to US$4.25 billion, including…

Read More

Aidoc picks up US$110 million to expand AI care platform

20 June 202220 June 2022

ISRAEL – Aidoc, a maker of AI-based software that helps radiologists read medical scans and alerts them to strokes or pulmonary embolisms, has pulled in a US$110 million Series D…

Read More

GE Healthcare to invest in Pulsenmore to enter homecare space

30 May 202230 May 2022

ISRAEL – GE Healthcare has agreed to invest up to US$50 million in Israeli start-up Pulsenmore in order to enter the homecare segment and facilitate precision health. The equity investment…

Read More

Saudi’s pharmacy chain Al Nahdi mulls US$1.3 billion IPO

3 February 20223 February 2022

SAUDI ARABIA –Saudi Arabia’s largest pharmacy retail chain plans to seek US$1.3 billion in an initial public offering in the coming months, Arabian Business has reported, citing sources privy to…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

LATEST NEWS

  • Amanat Holdings unveils its single platform Amanat Healthcare
  • Fujifilm expands its endoscopy portfolio with the launch of CAD EYE Upper GI in India
  • Redcliffe Labs snaps up Indian diagnostics chain Medicentre Sonography & Clinical Lab
  • JICA signs US$330M loan agreement for Egypt’s road to universal health insurance
  • New manufacturing unit to open at the VASCERA complex in Egypt

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Japan Johnson & Johnson Kenya Malaria Merck Mergers, Investments & Funding Middle East and North Africa Moderna MOH Kenya Nigeria Novartis Partnerships Pfizer Pharmaceuticals Public Health Roche Science & Technology South Africa Switzerland Tanzania UAE Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

Food Business Africa

Food Safety Africa

Milling Middle East & Africa

Sustainable Packaging Africa

CEO Business Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.